TRILOGIQ (ALTRI.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:ALTRI - FR0010397901 - Common Stock
5.2 EUR
0 (0%)
ALTRI gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 108 industry peers in the Machinery industry. ALTRI is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ALTRI has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
ALTRI had positive earnings in the past year.
In the past year ALTRI had a positive cash flow from operations.
In multiple years ALTRI reported negative net income over the last 5 years.
ALTRI had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
ALTRI has a Return On Assets (2.53%) which is comparable to the rest of the industry.
ALTRI has a Return On Equity of 2.80%. This is in the lower half of the industry: ALTRI underperforms 64.81% of its industry peers.
The Return On Invested Capital of ALTRI (0.57%) is worse than 78.70% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.53% | ||
| ROE | 2.8% | ||
| ROIC | 0.57% |
ROA(3y)1.54%
ROA(5y)N/A
ROE(3y)1.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of ALTRI (4.57%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of ALTRI has grown nicely.
Looking at the Operating Margin, with a value of 1.16%, ALTRI is doing worse than 79.63% of the companies in the same industry.
In the last couple of years the Operating Margin of ALTRI has grown nicely.
With an excellent Gross Margin value of 63.63%, ALTRI belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
ALTRI's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.16% | ||
| PM (TTM) | 4.57% | ||
| GM | 63.63% |
OM growth 3Y17.04%
OM growth 5YN/A
PM growth 3Y25.71%
PM growth 5YN/A
GM growth 3Y1.99%
GM growth 5Y12.3%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALTRI is destroying value.
The number of shares outstanding for ALTRI remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ALTRI has about the same amount of shares outstanding.
ALTRI has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 5.51 indicates that ALTRI is not in any danger for bankruptcy at the moment.
ALTRI has a Altman-Z score of 5.51. This is amongst the best in the industry. ALTRI outperforms 92.59% of its industry peers.
ALTRI has a debt to FCF ratio of 0.01. This is a very positive value and a sign of high solvency as it would only need 0.01 years to pay back of all of its debts.
ALTRI has a Debt to FCF ratio of 0.01. This is amongst the best in the industry. ALTRI outperforms 99.07% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that ALTRI is not too dependend on debt financing.
ALTRI has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. ALTRI outperforms 97.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.01 | ||
| Altman-Z | 5.51 |
ROIC/WACC0.07
WACC8.08%
2.3 Liquidity
A Current Ratio of 9.71 indicates that ALTRI has no problem at all paying its short term obligations.
ALTRI has a Current ratio of 9.71. This is amongst the best in the industry. ALTRI outperforms 99.07% of its industry peers.
A Quick Ratio of 8.58 indicates that ALTRI has no problem at all paying its short term obligations.
The Quick ratio of ALTRI (8.58) is better than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 9.71 | ||
| Quick Ratio | 8.58 |
3. Growth
3.1 Past
ALTRI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -32.65%.
ALTRI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 29.14% yearly.
ALTRI shows a decrease in Revenue. In the last year, the revenue decreased by -3.60%.
The Revenue has been decreasing by -0.29% on average over the past years.
EPS 1Y (TTM)-32.65%
EPS 3Y29.14%
EPS 5YN/A
EPS Q2Q%-122.02%
Revenue 1Y (TTM)-3.6%
Revenue growth 3Y2.81%
Revenue growth 5Y-0.29%
Sales Q2Q%-14%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-2.78%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.12%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 17.93, the valuation of ALTRI can be described as rather expensive.
Based on the Price/Earnings ratio, ALTRI is valued a bit cheaper than 70.37% of the companies in the same industry.
ALTRI's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.46.
A Price/Forward Earnings ratio of 14.42 indicates a correct valuation of ALTRI.
The rest of the industry has a similar Price/Forward Earnings ratio as ALTRI.
ALTRI is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.10, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.93 | ||
| Fwd PE | 14.42 |
4.2 Price Multiples
ALTRI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ALTRI is cheaper than 78.70% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.83 | ||
| EV/EBITDA | -23.67 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for ALTRI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:ALTRI (12/5/2025, 7:00:00 PM)
5.2
0 (0%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners1.72%
Inst Owner ChangeN/A
Ins Owners76.77%
Ins Owner ChangeN/A
Market Cap19.45M
Revenue(TTM)23.20M
Net Income(TTM)1.06M
Analysts86.67
Price Target6.12 (17.69%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.93 | ||
| Fwd PE | 14.42 | ||
| P/S | 0.84 | ||
| P/FCF | 8.83 | ||
| P/OCF | 8.05 | ||
| P/B | 0.51 | ||
| P/tB | 0.51 | ||
| EV/EBITDA | -23.67 |
EPS(TTM)0.29
EY5.58%
EPS(NY)0.36
Fwd EY6.93%
FCF(TTM)0.59
FCFY11.33%
OCF(TTM)0.65
OCFY12.42%
SpS6.2
BVpS10.14
TBVpS10.13
PEG (NY)N/A
PEG (5Y)N/A
Graham Number8.13
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.53% | ||
| ROE | 2.8% | ||
| ROCE | 0.7% | ||
| ROIC | 0.57% | ||
| ROICexc | 1.67% | ||
| ROICexgc | 1.67% | ||
| OM | 1.16% | ||
| PM (TTM) | 4.57% | ||
| GM | 63.63% | ||
| FCFM | 9.49% |
ROA(3y)1.54%
ROA(5y)N/A
ROE(3y)1.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y31.78%
ROICexgc growth 5YN/A
ROICexc growth 3Y31.69%
ROICexc growth 5YN/A
OM growth 3Y17.04%
OM growth 5YN/A
PM growth 3Y25.71%
PM growth 5YN/A
GM growth 3Y1.99%
GM growth 5Y12.3%
F-Score6
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.01 | ||
| Debt/EBITDA | 0.02 | ||
| Cap/Depr | 24.77% | ||
| Cap/Sales | 0.91% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 214.48% | ||
| Profit Quality | 207.83% | ||
| Current Ratio | 9.71 | ||
| Quick Ratio | 8.58 | ||
| Altman-Z | 5.51 |
F-Score6
WACC8.08%
ROIC/WACC0.07
Cap/Depr(3y)38.04%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.5%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-32.65%
EPS 3Y29.14%
EPS 5YN/A
EPS Q2Q%-122.02%
EPS Next Y-2.78%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.6%
Revenue growth 3Y2.81%
Revenue growth 5Y-0.29%
Sales Q2Q%-14%
Revenue Next Year5.12%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-68.86%
EBIT growth 3Y20.32%
EBIT growth 5YN/A
EBIT Next Year187.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.85%
FCF growth 3YN/A
FCF growth 5Y-4.81%
OCF growth 1Y-14.72%
OCF growth 3YN/A
OCF growth 5Y-3.83%
TRILOGIQ / ALTRI.PA FAQ
What is the ChartMill fundamental rating of TRILOGIQ (ALTRI.PA) stock?
ChartMill assigns a fundamental rating of 5 / 10 to ALTRI.PA.
What is the valuation status of TRILOGIQ (ALTRI.PA) stock?
ChartMill assigns a valuation rating of 4 / 10 to TRILOGIQ (ALTRI.PA). This can be considered as Fairly Valued.
Can you provide the profitability details for TRILOGIQ?
TRILOGIQ (ALTRI.PA) has a profitability rating of 4 / 10.
What are the PE and PB ratios of TRILOGIQ (ALTRI.PA) stock?
The Price/Earnings (PE) ratio for TRILOGIQ (ALTRI.PA) is 17.93 and the Price/Book (PB) ratio is 0.51.
Can you provide the financial health for ALTRI stock?
The financial health rating of TRILOGIQ (ALTRI.PA) is 9 / 10.